Domatinostat in Combination With Avelumab in Patients With Treatment-naïve Metastatic Merkel Cell Carcinoma (MERKLIN 1)

Clinical trial NCT04874831 · WITHDRAWN

Trial details

NCT number: NCT04874831
Sponsor: 4SC AG
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Merkel Cell Carcinoma

Start date: 2021-11-01
Primary completion: 2025-09-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.